In prostate cancer cells, the interaction mechanisms between specific SFAs (such as myristic acid and palmitic acid) and cell membrane receptors or intracellular proteins, as well as the specific processes by which this interaction initiates the activation of the NF-κB pathway, remain unclear. The gene discussed is NFKB1; the disease is prostate carcinoma.